Amber Nigam

I am a healthcare entrepreneur with over fourteen years of experience at the intersection of AI and healthcare. As the co-founder and CEO of basys.ai, I lead the strategy, business development, and fundraising efforts. At basys.ai, we focus on using generative AI to address key challenges in prior authorization and utilization management, aiming to make care more patient-centric, accessible, and efficient. This work is deeply personal. After seeing my father’s struggle with delayed medical treatments, I co-founded basys.ai to address the administrative inefficiencies that contribute to such delays. Our team, which includes experts from organizations like Kaiser Permanente, Mass General Brigham, WHO, UN, Cerner, Stanford University School of Medicine, MIT, and Harvard, is backed by reputable institutions such as Mayo Clinic, Eli Lilly, Highmark, and CareFirst Blue Cross Blue Shield. I hold a bachelor’s in Computer Science and an MS in Health Data Science from Harvard University, where I was a Cheng Fellow and Roslyn & Lisle Payne Scholar. I have been recognized as one of the 40 Under 40 by the Boston Congress of Public Health. Previously, I founded Kydots.ai, leading the company through its growth and successful acquisition. My passion for building and scaling ventures extends to mentoring startups at TechStars, Harvard, MIT, MassChallenge, and XLerateHealth. I’ve also co-instructed an MIT course on AI applications in healthcare, where I explored how technology can directly improve patient care. As a former co-Director of the Harvard Business Club, I provided strategic and fundraising support to Harvard-affiliated founders, helping them transform their ideas into impactful businesses. Beyond entrepreneurship, I contribute to shaping the healthcare and AI conversation. I’ve authored Op-Ed articles in Harvard Business Review, STAT News, Becker’s Healthcare, and Forbes and have shared insights on global platforms, including TEDx, Mayo Clinic, DuPont, and Udacity. The companies I’ve founded have been featured in Forbes and TechCrunch, highlighting their impact and innovation in AI and healthcare.